Terug
Dagbereik
€ 22,85
€ 23,96
52-Weeksbereik
€ 11,09
€ 23,96
Volume
578.872
50D / 200D Gem.
€ 16,72
/
€ 16,77
Vorige Slotkoers
€ 23,81
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -136,2 | 0,3 |
| P/B | 24,0 | 2,9 |
| ROE % | -18,2 | 3,7 |
| Net Margin % | -5,8 | 3,8 |
| Rev Growth 5Y % | 38,3 | 10,0 |
| D/E | 0,4 | 0,2 |
Koersdoel Analisten
Hold
€ 25,00
+8.8%
Low: € 15,00
High: € 35,00
Forward K/W
28,7
Forward WPA
€ 0,83
WPA Groei (sch.)
+0,0%
Omzet Sch.
110 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 5,87
€ 5,53 – € 6,23
|
410 M | 1 |
| FY2029 |
€ 4,36
€ 4,11 – € 4,63
|
320 M | 1 |
| FY2028 |
€ 2,68
€ 2,02 – € 3,42
|
220 M | 3 |
Belangrijkste Punten
Revenue grew 38,33% annually over 5 years — strong growth
Debt/Equity of 0,35 — conservative balance sheet
Generating 10,19M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 66,61%
Capital efficient — spends only 0,42% of revenue on capex
ROIC of 0,15% — low return on invested capital
Groei
Revenue Growth (5Y)
38,33%
Revenue (1Y)104,94%
Earnings (1Y)N/A
FCF Growth (3Y)29,89%
Kwaliteit
Return on Equity
-18,19%
ROIC0,15%
Net Margin-5,75%
Op. Margin0,09%
Veiligheid
Debt / Equity
0,35
Current Ratio1,57
Interest Coverage0,02
Waardering
P/E Ratio
-136,21
P/B Ratio23,96
EV/EBITDA8472,66
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 104,94% | Revenue Growth (3Y) | 58,96% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 38,33% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 79,95M | Net Income (TTM) | -4,60M |
| ROE | -18,19% | ROA | -4,99% |
| Gross Margin | 53,46% | Operating Margin | 0,09% |
| Net Margin | -5,75% | Free Cash Flow (TTM) | 10,19M |
| ROIC | 0,15% | FCF Growth (3Y) | 29,89% |
| Safety | |||
| Debt / Equity | 0,35 | Current Ratio | 1,57 |
| Interest Coverage | 0,02 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -136,21 | P/B Ratio | 23,96 |
| P/S Ratio | 7,84 | PEG Ratio | -7,42 |
| EV/EBITDA | 8472,66 | Dividend Yield | 0,00% |
| Market Cap | 626,72M | Enterprise Value | 610,03M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 79,95M | 39,01M | 31,64M | 21,25M | 21,83M |
| Net Income | -4,60M | -3,82M | -936.000,0 | -9,02M | -1,96M |
| EPS (Diluted) | -0,17 | -0,15 | -0,04 | -0,36 | -0,08 |
| Gross Profit | 42,74M | 23,41M | 21,06M | 14,32M | 19,21M |
| Operating Income | 72.000,0 | -2,60M | -1,19M | -8,26M | -1,50M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 92,11M | 76,12M | 31,74M | 25,03M | 27,47M |
| Total Liabilities | 65,96M | 51,70M | 16,26M | 11,95M | 9,84M |
| Shareholders' Equity | 26,15M | 24,43M | 15,48M | 13,08M | 17,63M |
| Total Debt | 9,25M | 29,92M | 5,40M | 6,52M | 6,70M |
| Cash & Equivalents | 25,94M | 14,94M | 21,39M | 16,31M | 14,41M |
| Current Assets | 60,58M | 41,02M | 26,84M | 20,00M | 23,60M |
| Current Liabilities | 38,49M | 19,95M | 16,24M | 6,46M | 4,56M |